Literature DB >> 8428285

Myocardial infarction after reconstruction of the abdominal aorta.

M Kalra1, D Charlesworth, J A Morris, H al-Khaffaf.   

Abstract

The records of 555 patients who underwent elective abdominal aortic reconstruction were analysed to identify risk factors predisposing to cardiac complications. Perioperative myocardial infarction occurred in 35 patients (6.3 per cent), of whom 12 (2.2 per cent) died. Using multiple logistic regression, four preoperative factors that were independently predictive for postoperative myocardial infarction were identified with the following relative risk ratios: history of transient ischaemic attacks, 5.08; raised serum creatinine level, 3.66; age > 60 years, 3.00; and angina requiring regular treatment, 2.74. A scoring system using these four factors was devised that identified 150 of the 555 patients as at high risk, and included 69 per cent of those with myocardial infarction after operation and 83 per cent of those who died. A clinical risk score is a practical first step in identifying patients at risk of myocardial infarction; it would also reduce the number of patients for whom sophisticated tests of cardiac function were necessary.

Entities:  

Mesh:

Year:  1993        PMID: 8428285     DOI: 10.1002/bjs.1800800110

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  3 in total

1.  Outcomes after redo aortobifemoral bypass for aortoiliac occlusive disease.

Authors:  Salvatore T Scali; Bradley M Schmit; Robert J Feezor; Adam W Beck; Catherine K Chang; Alyson L Waterman; Scott A Berceli; Thomas S Huber
Journal:  J Vasc Surg       Date:  2014-03-21       Impact factor: 4.268

2.  Perioperative myocardial infarction in peripheral vascular surgery.

Authors:  N Mamode; R N Scott; S C McLaughlin; A McLelland; J G Pollock
Journal:  BMJ       Date:  1996-06-01

3.  Contemporary outcomes of thoracofemoral bypass.

Authors:  Jeffrey D Crawford; Salvatore T Scali; Kristina A Giles; Martin R Back; Javairiah Fatima; Dean K Arnaoutakis; Scott A Berceli; Gilbert J Upchurch; Thomas S Huber
Journal:  J Vasc Surg       Date:  2018-10-03       Impact factor: 4.268

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.